FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved Teva's supplemental NDA for Fluticasone propionate and salmeterol, expanding its labeling and approved uses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fluticasone Propionate and Salmeterol (Fluticasone Propionate and Salmeterol)

Snippet

SUPPL AP for FLUTICASONE PROPIONATE AND SALMETEROL (FLUTICASONE PROPIONATE AND SALMETEROL)